TGFB2 and familial pancreatic carcinoma: Taken together, our findings indicated that miR-193a antagonist could effectively block pancreatic cancer repopulation, reduce spontaneous liver metastasis and prolong the survival through modulating TGF-β2/TGF-βRIII signalings.